Zuo WJ, Ma LX, Wang ZH, Cao XC, et al. Efficacy and safety of inetetamab plus pertuzumab and nab-paclitaxel as neoadjuvant therapy for HER2+ breast cancer: A single-arm multicenter phase II clinical trial. Cancer Lett 2025 May 10:217785. doi: 10.1016/j.canlet.2025.217785.
PMID: 40354993